Daiichi Sankyo and AstraZeneca’s Enhertu Plus Pertuzumab Approved in China for First-Line HER2+ Metastatic Breast Cancer
FDA is Announcing an Upcoming Meeting
Financial Toxicity in Cancer Care: A Global Call for Submissions
Julie Gralow on Why Federal Funding Matters for the Future of Cancer Research
Medical Oncology vs Radiation Oncology: Who Does What in Cancer Care?
ctDNA in Early Breast Cancer: Powerful Promise, Key Gaps
Alejandra Mendez Highlights the Impact of the Zero Abandonment Programme in Childhood Cancer
Shane Jacobson: New $5.45 Million Fund to Empower the Next Generation of Cancer Scientists
